Berry Street Capital Management LLP Aurinia Pharmaceuticals Inc. Transaction History

Berry Street Capital Management LLP

  • $340 Million
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$8.95 - $12.8 $671,250 - $960,000
-75,000 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$10.05 - $22.48 $1.07 Million - $2.39 Million
-106,250 Reduced 58.62%
75,000 $929,000
Q4 2021

Feb 10, 2022
BUY
$17.78 - $33.08 $555,625 - $1.03 Million
31,250 Added 20.83%
181,250 $4.15 Million
Q3 2021

Nov 12, 2021
BUY
$10.93 - $23.55 $1.64 Million - $3.53 Million
150,000 New
150,000 $3.32 Million

Others Institutions Holding AUPH

# of Institutions
191
Shares Held
56.2M
Call Options Held
499K
Put Options Held
637K
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.03B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Berry Street Capital Management LLP Portfolio

Follow Berry Street Capital Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berry Street Capital Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Berry Street Capital Management LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email